Literature DB >> 21554418

Activation of the human complement system by pigmented and hypopigmented mycelia of the fungus Fonsecaea pedrosoi.

Lysianne Pinto1, Luiz Fernando Zmetek Granja, Daniela Sales Alviano, Maria Helena da Silva, Celuta Sales Alviano, Regina Ejzemberg.   

Abstract

The action of the complement system on pigmented and hypopigmented mycelia of the fungus Fonsecaea pedrosoi, the major aetiological pathogen of the chromoblastomycosis is herein discussed. Fungi were grown in medium Czapeck-Dox at 37°C, for 14 days, without shaking to obtain pigmented mycelium. To obtain hypopigmented mycelium, the fungus was grown at the same conditions, but in the dark and with low oxygenation. Activation was measured by complement consumption and enzyme-linked immunosorbent assay. We also observed by immunofluorescence the deposition of C3, C4 fragments and C9 on the surface of the different forms studied. The results indicate that both forms were able to activate the complement system mainly by the alternative pathway. Pigmented mycelia had the highest consumption results, indicating that the pigment, melanin, may have influence in activation.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554418     DOI: 10.1111/j.1439-0507.2010.01956.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  4 in total

1.  Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.

Authors:  Daiane Heidrich; Danielle Machado Pagani; Alessandra Koehler; Karine de Oliveira Alves; Maria Lúcia Scroferneker
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

2.  Melanin particles isolated from the fungus Fonsecaea pedrosoi activates the human complement system.

Authors:  Lysianne Pinto; Luiz Fernando Zmetek Granja; Mariana Amorim de Almeida; Daniela Sales Alviano; Maria Helena da Silva; Regina Ejzemberg; Sonia Rozental; Celuta Sales Alviano
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-06-25       Impact factor: 2.743

Review 3.  Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis.

Authors:  Leandro C D Breda; Isabela G Menezes; Larissa N M Paulo; Sandro Rogério de Almeida
Journal:  J Fungi (Basel)       Date:  2020-12-22

Review 4.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.